Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database

INTRODUCTION: Oral glucocorticoids (GC) have been the mainstay of treatment for giant cell arteritis (GCA). We estimated the risk and dose–effect relationship of potential GC-related adverse events (AEs) in patients with GCA. METHODS: This retrospective, observational cohort study utilized data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Best, Jennie H., Kong, Amanda M., Unizony, Sebastian, Tran, Oth, Michalska, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858477/
https://www.ncbi.nlm.nih.gov/pubmed/31656021
http://dx.doi.org/10.1007/s40744-019-00180-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858477/
https://www.ncbi.nlm.nih.gov/pubmed/31656021
http://dx.doi.org/10.1007/s40744-019-00180-9

Ejemplares similares